NCT03921853

Brief Summary

The researchers will conduct a study for avoiding the metabolic syndrome in morbid obese patients. Thus, the aim of the present will be determine the effects of a resistance training programme (RT) in preventing or attenuating metabolic syndrome (MetS) in patients with morbid obesity. A second aim will be report the prevalence of non-responders in terms of improvements in MetS markers and other co-variables considered.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2018

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 8, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 19, 2019

Completed
Last Updated

April 19, 2019

Status Verified

April 1, 2019

Enrollment Period

3 months

First QC Date

April 8, 2019

Last Update Submit

April 16, 2019

Conditions

Outcome Measures

Primary Outcomes (5)

  • Fasting glucose

    Component of the Metabolic Syndrome

    Change from Baseline Fasting glucose at 20-weeks of Resistant Training

  • High density lipoprotein

    Component of the Metabolic Syndrome

    Change from Baseline High density lipoprotein at 20-weeks of Resistant Training

  • Systolic blood pressure and diastolic blood pressure

    Component of the Metabolic Syndrome

    from Baseline Systolic blood pressure and diastolic blood after 20-weeks of Resistant Training

  • Waist circumference

    Component of the Metabolic Syndrome

    Change from Baseline Waist circumference at 20-weeks of Resistant Training

  • Triglycerides

    Component of the Metabolic Syndrome

    Change from Baseline Triglycerides at 20-weeks of Resistant Training

Secondary Outcomes (7)

  • Body mass index

    Change from Baseline Body mass index at 20-weeks of Resistant Training

  • Body mass

    Change from Baseline Body mass at 20-weeks of Resistant Training

  • Total cholesterol

    Change from Baseline Total cholesterol at 20-weeks of Resistant Training

  • Low density lipoprotein

    Change from Baseline Low density lipoprotein at 20-weeks of Resistant Training

  • Six minutes walking test

    Change from Baseline Six minutes walking test density lipoprotein at 20-weeks of Resistant Training

  • +2 more secondary outcomes

Study Arms (2)

Active comparator

ACTIVE COMPARATOR

Control group with obesity under Resistant Training

Other: Behavioral

Experimental group with morbid obesity

EXPERIMENTAL

Experimental group with morbid obesity under Resistant Training

Other: Behavioral

Interventions

The 20-week RT program will consist of three sessions per week, each lasting for 1 hour that will be applied to both control obese (CG) and morbid obese (MO) group. All sessions will start with 15 minutes warm-up with continuous walking and joint mobility and flexibility exercises, 5 minutes of cool down and stretching, in order for preventing injuries. Sessions will include 4 to 8 RT exercises targeting different muscle groups; 1. forearm, 2. knee flexors and 3. extensors, 3. trunk, 4. chest, 5. shoulder elevators, 6. horizontal shoulder flexors and 7. extensors, and 8. plantar flexors. The exercises for each muscle group will be performed in 3 sets of as many repetitions (continuous concentric/eccentric voluntary contraction) possible in 1 minute followed by 2.0 minutes of passive recovery. Before the RT program, each participant will be measure using the subjective modified Borg scale (1-10 points), in order of identifying the muscle failure into 1 minute of exercise.

Also known as: Resistant training intervention
Active comparatorExperimental group with morbid obesity

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older than 18 and younger and ≤65 years of age.
  • With risk factors to Metabolic syndrome
  • With obesity and morbid obesity condition
  • Medical authorization by a physician.

You may not qualify if:

  • Physical limitations (e.g., restricting injuries of the musculoskeletal system, or dependent of a third person).
  • Exercise-related dyspnoea or respiratory alterations.
  • Chronic heart disease with any worsening in the last month.
  • Adherence rate of less than 80% of the total interventions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cristian ALvarez

Osorno, Llanquihue, 5290000, Chile

Location

Related Publications (1)

  • Delgado-Floody P, Alvarez C, Lusa Cadore E, Flores-Opazo M, Caamano-Navarrete F, Izquierdo M. Preventing metabolic syndrome in morbid obesity with resistance training: Reporting interindividual variability. Nutr Metab Cardiovasc Dis. 2019 Dec;29(12):1368-1381. doi: 10.1016/j.numecd.2019.07.002. Epub 2019 Jul 12.

MeSH Terms

Conditions

Obesity, MorbidObesityMotor ActivityMetabolic Syndrome

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Study Officials

  • Cristian ALvarez, PhD

    Universidad de Los Lagos

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
According with the availability and the feasibility of the enrolment's requirements, patients will be allocated to a control group with obesity, and another with morbid obesity.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: We will compare a control group with obesity with another experimental group with morbid obesity in the metabolic syndrome parameters.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2019

First Posted

April 19, 2019

Study Start

January 1, 2018

Primary Completion

April 4, 2018

Study Completion

April 30, 2018

Last Updated

April 19, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

The participants information will be available by e-mail according with researchers requirements.

Locations